CAS RN: 382-44-5
11β-Hydroxyandrost-4-ene-3,17-dione
Product Availability
Choose a grade to view its available package options.
10 package records10 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250626 |
10mg |
In stock |
| Inquiry |
| Batchno.20250502 |
250mg |
In stock |
| Inquiry |
| Batchno.20260403 |
50mg |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260605 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260527 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250506 |
10mg |
In stock |
Shanghai, Shandong, Hebei | Inquiry |
| Batchno.20250416 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251216 |
25mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250921 |
50mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251226 |
50mg |
In stock |
Shandong | Inquiry |
-
Product code:
starshine_CAS382-44-5
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
382-44-5 / (8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
Standard CAS: 382-44-5
Multi CAS: No
Basic Information
CAS
382-44-5
Multi CAS
No
Molecular Formula
C19H26O3
Molecular Weight
302.400000
Exact Mass
302.188195
InChI
InChI=1S/C19H26O3/c1-18-8-7-12(20)9-11(18)3-4-13-14-5-6-16(22)19(14,2)10-15(21)17(13)18/h9,13-15,17,21H,3-8,10H2,1-2H3/t13-,14-,15-,17+,18-,19-/m0/s1
InChIKey
WSCUHXPGYUMQEX-KCZNZURUSA-N
Physical Properties
Physical Description
Solid
State
Solid
Computed Properties
Structural Parameters
Heavy atom count
22
Fraction Csp3
0.79
H-bond acceptors
3
H-bond donors
1
Molar refractivity
83.11
TPSA
54.37
LogP / Solubility
WLOGP
3.06
MLOGP
2.7
XLogP3
1.6
Consensus LogP
2.45
Log S (ESOL)
-3.64
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.25
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.16
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.39
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
6